Regulations, liability, safety, and economics related to compounding.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 31821858.
- Also identified by DOI 10.1016/j.jaad.2019.11.061.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Extemporaneous compounding is a means to tailor a medication to an individual patient's needs and may be required when no commercial product exists to meet that need. Compounded products range from buffered lidocaine to topical creams and ointments. Recent heightened regulations have made compounding more challenging for dermatologists and prompted this review of regulations, liability, and safety related to compounding. With this information, providers may minimize liability and maximize safety while caring for their patients.
Medical subject headings
- Drug Compounding